The stock of SalvaRx Group Plc (LON:SALV) is a huge mover today! The stock decreased 1.92% or GBX 0.62 on November 8, hitting GBX 31.88. About 298 shares traded hands. SalvaRx Group Plc (LON:SALV) has risen 8.33% since April 8, 2016 and is uptrending. It has outperformed by 6.38% the S&P500.
The move comes after 5 months positive chart setup for the GBX 11.89M company. It was reported on Nov, 8 by Barchart.com. We have GBX 87.67 PT which if reached, will make LON:SALV worth GBX 20.81M more.
More news for SalvaRx Group Plc (LON:SALV) were recently published by: Businesswire.com, which released: “Intensity Therapeutics, Inc. Raises $10 Million to Fund Clinical Supplies …” on June 28, 2016. Fortune.com‘s article titled: “Term Sheet — Tuesday, June 28” and published on June 28, 2016 is yet another important article.
SalvaRx Group plc, formerly 3Legs Resources plc, is an investing company. The company has a market cap of 11.89 million GBP. The Firm is engaged in drug discovery and development, focused on immune-oncology. It currently has negative earnings. The Company’s segment is appraisal of investment targets meeting the Company’s investment policy.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.